Timber pharmaceuticals provides business update and announces third quarter 2021 financial results

Positive top line phase 2b study data for lead asset tmb-001 and capital rais e of $17.25 million announced subsequent to quarter end

TMBR Ratings Summary

TMBR Quant Ranking